APO Research
Talk to an analyst

APO RESEARCH · REPORT

Deoxyribonucleic Acid and Ribonucleic Acid Banking Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Outlook and Growth Opportunities 2026

11 April 2026Not stated

Choose your research edition.

Industry ResearchDeoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Analysis and Forecast 2026-2032182 pages · $4,950 USD

Market perspective

The global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Deoxyribonucleic Acid and Ribonucleic Acid Banking Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Deoxyribonucleic Acid and Ribonucleic Acid Banking Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Deoxyribonucleic Acid and Ribonucleic Acid Banking Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market include Thermo Fisher Scientific, BioStorage Technologies Inc., Life Technologies, BGI Group, DNA Genotek, Hamilton Company, Integrated DNA Technologies, Promega Corporation and Qiagen N.V., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Deoxyribonucleic Acid and Ribonucleic Acid Banking Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market.

Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Segment by Company

Thermo Fisher Scientific

BioStorage Technologies Inc.

Life Technologies

BGI Group

DNA Genotek

Hamilton Company

Integrated DNA Technologies

Promega Corporation

Qiagen N.V.

Tecan Group Ltd.

Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Segment by Type

Transportation

Processing

Storage

Quality Control

Data Storage

Others

Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Segment by Application

Academic Research

Pharmaceutical & Biotechnology Companies

Hospitals & Diagnostic Centers

Others

Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Deoxyribonucleic Acid and Ribonucleic Acid Banking Services key companies, revenue, market share, and recent developments.

3. To split the Deoxyribonucleic Acid and Ribonucleic Acid Banking Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Deoxyribonucleic Acid and Ribonucleic Acid Banking Services significant trends, drivers, influence factors in global and regions.

6. To analyze Deoxyribonucleic Acid and Ribonucleic Acid Banking Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services industry.

Chapter 3: Detailed analysis of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Trends Table 2. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Drivers Table 3. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Opportunities and Challenges Table 4. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Restraints Table 5. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue Share by Company (2021-2026) Table 7. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Key Company Manufacturing Base & Headquarters Table 9. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company, Product Type & Application Table 10. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Transportation Table 15. Significant Companies of Processing Table 16. Significant Companies of Storage Table 17. Significant Companies of Quality Control Table 18. Significant Companies of Data Storage Table 19. Significant Companies of Others Table 20. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type (2021-2026) Table 24. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Academic Research Table 26. Significant Companies of Pharmaceutical & Biotechnology Companies Table 27. Significant Companies of Hospitals & Diagnostic Centers Table 28. Significant Companies of Others Table 29. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application (2021-2026) Table 33. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application (2027-2032) Table 34. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Region (2021-2026) Table 37. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Region (2027-2032) Table 39. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Market Share by Country (2021-2026) Table 42. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Market Share by Country (2027-2032) Table 44. Thermo Fisher Scientific Company Information Table 45. Thermo Fisher Scientific Business Overview Table 46. Thermo Fisher Scientific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Thermo Fisher Scientific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 48. Thermo Fisher Scientific Recent Development Table 49. BioStorage Technologies Inc. Company Information Table 50. BioStorage Technologies Inc. Business Overview Table 51. BioStorage Technologies Inc. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. BioStorage Technologies Inc. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 53. BioStorage Technologies Inc. Recent Development Table 54. Life Technologies Company Information Table 55. Life Technologies Business Overview Table 56. Life Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Life Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 58. Life Technologies Recent Development Table 59. BGI Group Company Information Table 60. BGI Group Business Overview Table 61. BGI Group Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. BGI Group Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 63. BGI Group Recent Development Table 64. DNA Genotek Company Information Table 65. DNA Genotek Business Overview Table 66. DNA Genotek Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. DNA Genotek Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 68. DNA Genotek Recent Development Table 69. Hamilton Company Company Information Table 70. Hamilton Company Business Overview Table 71. Hamilton Company Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Hamilton Company Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 73. Hamilton Company Recent Development Table 74. Integrated DNA Technologies Company Information Table 75. Integrated DNA Technologies Business Overview Table 76. Integrated DNA Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Integrated DNA Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 78. Integrated DNA Technologies Recent Development Table 79. Promega Corporation Company Information Table 80. Promega Corporation Business Overview Table 81. Promega Corporation Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Promega Corporation Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 83. Promega Corporation Recent Development Table 84. Qiagen N.V. Company Information Table 85. Qiagen N.V. Business Overview Table 86. Qiagen N.V. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Qiagen N.V. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 88. Qiagen N.V. Recent Development Table 89. Tecan Group Ltd. Company Information Table 90. Tecan Group Ltd. Business Overview Table 91. Tecan Group Ltd. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Tecan Group Ltd. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio Table 93. Tecan Group Ltd. Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Image Figure 2. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Transportation Image Figure 8. Processing Image Figure 9. Storage Image Figure 10. Quality Control Image Figure 11. Data Storage Image Figure 12. Others Image Figure 13. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type (2021-2032) Figure 16. Academic Research Image Figure 17. Pharmaceutical & Biotechnology Companies Image Figure 18. Hospitals & Diagnostic Centers Image Figure 19. Others Image Figure 20. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application (2021-2032) Figure 23. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032) & (US$ Million) Figure 26. North America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032) & (US$ Million) Figure 32. South America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Transportation
  • Processing
  • Storage
  • Quality Control
  • Data Storage
  • Others
Applications
  • Academic Research
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Centers
  • Others
Companies covered
  • Thermo Fisher Scientific
  • BioStorage Technologies Inc.
  • Life Technologies
  • BGI Group
  • DNA Genotek
  • Hamilton Company
  • Integrated DNA Technologies
  • Promega Corporation
  • Qiagen N.V.
  • Tecan Group Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Dynamics
  1. 2.1 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Trends
  2. 2.2 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Drivers
  3. 2.3 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Opportunities and Challenges
  4. 2.4 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Restraints
3 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market by Company
  1. 3.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company Revenue Ranking in 2025
  2. 3.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue by Company (2021-2026)
  3. 3.3 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company Ranking (2024-2026)
  4. 3.4 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company Product Type and Application
  6. 3.6 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market by Type
  1. 4.1 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Type Introduction
  2. 4.1.1 Transportation
  3. 4.1.2 Processing
  4. 4.1.3 Storage
  5. 4.1.4 Quality Control
  6. 4.1.5 Data Storage
  7. 4.1.6 Others
  8. 4.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Type
  9. 4.2.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Type (2021-2032)
  11. 4.2.3 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type (2021-2032)
5 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market by Application
  1. 5.1 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Application Introduction
  2. 5.1.1 Academic Research
  3. 5.1.2 Pharmaceutical & Biotechnology Companies
  4. 5.1.3 Hospitals & Diagnostic Centers
  5. 5.1.4 Others
  6. 5.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Application
  7. 5.2.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application (2021-2032)
6 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Regional Value Analysis
  1. 6.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032)
  7. 6.3.2 North America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032)
  10. 6.4.2 Europe Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032)
  16. 6.6.2 South America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Country, 2025 VS 2032
7 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Country-level Value Analysis
  1. 7.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 BioStorage Technologies Inc.
  8. 8.2.1 BioStorage Technologies Inc. Company Information
  9. 8.2.2 BioStorage Technologies Inc. Business Overview
  10. 8.2.3 BioStorage Technologies Inc. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioStorage Technologies Inc. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  12. 8.2.5 BioStorage Technologies Inc. Recent Developments
  13. 8.3 Life Technologies
  14. 8.3.1 Life Technologies Company Information
  15. 8.3.2 Life Technologies Business Overview
  16. 8.3.3 Life Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Life Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  18. 8.3.5 Life Technologies Recent Developments
  19. 8.4 BGI Group
  20. 8.4.1 BGI Group Company Information
  21. 8.4.2 BGI Group Business Overview
  22. 8.4.3 BGI Group Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BGI Group Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  24. 8.4.5 BGI Group Recent Developments
  25. 8.5 DNA Genotek
  26. 8.5.1 DNA Genotek Company Information
  27. 8.5.2 DNA Genotek Business Overview
  28. 8.5.3 DNA Genotek Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DNA Genotek Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  30. 8.5.5 DNA Genotek Recent Developments
  31. 8.6 Hamilton Company
  32. 8.6.1 Hamilton Company Company Information
  33. 8.6.2 Hamilton Company Business Overview
  34. 8.6.3 Hamilton Company Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hamilton Company Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  36. 8.6.5 Hamilton Company Recent Developments
  37. 8.7 Integrated DNA Technologies
  38. 8.7.1 Integrated DNA Technologies Company Information
  39. 8.7.2 Integrated DNA Technologies Business Overview
  40. 8.7.3 Integrated DNA Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Integrated DNA Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  42. 8.7.5 Integrated DNA Technologies Recent Developments
  43. 8.8 Promega Corporation
  44. 8.8.1 Promega Corporation Company Information
  45. 8.8.2 Promega Corporation Business Overview
  46. 8.8.3 Promega Corporation Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Promega Corporation Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  48. 8.8.5 Promega Corporation Recent Developments
  49. 8.9 Qiagen N.V.
  50. 8.9.1 Qiagen N.V. Company Information
  51. 8.9.2 Qiagen N.V. Business Overview
  52. 8.9.3 Qiagen N.V. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qiagen N.V. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  54. 8.9.5 Qiagen N.V. Recent Developments
  55. 8.10 Tecan Group Ltd.
  56. 8.10.1 Tecan Group Ltd. Company Information
  57. 8.10.2 Tecan Group Ltd. Business Overview
  58. 8.10.3 Tecan Group Ltd. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tecan Group Ltd. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
  60. 8.10.5 Tecan Group Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst